Insights into Drug Pricing and Payers' Perspectives in Japanese Ophthalmology
The objective of this qualitative study was to gain insights into drug pricing policies and payers' perspectives on efficacy, specifically for ophthalmological diseases such as neovascular age-related macular degeneration (nAMD). The study targeted a rare and unique group of specialists.
The recruitment process spanned three weeks, followed by a three-day interview period with three participants. This study illustrated the challenges of reaching such a niche target audience, as the payer’s component was the most demanding aspect due to Japan's unique insurance policies. Despite these hurdles, the study successfully engaged with these rare specialists, providing valuable insights into drug pricing and efficacy impressions from the payers' perspective within the ophthalmology therapeutic area.
Tracking Study with PRFs in Hong Kong
We conducted a two-wave market tracking study focusing on various disease treatments, including Type 2 Diabetes Management, Heart Failure, and Chronic Kidney Disease in Hong Kong. The objective was to understand brand awareness and usage performance of various brands in these therapy areas. The survey, lasting 60 minutes, included the main survey and five patient record forms.
In each wave, we collected responses from 47 doctors working in public hospitals (including endocrinologists, cardiologists, nephrologists, GOPC, and family medicine) and 21 doctors working in private hospitals (endocrinologists, cardiologists, nephrologists). All doctors were recruited from a target list. Fieldwork for each wave was completed within six weeks.
Current and Future Perspectives on Multiple Myeloma Treatment in Japan
This qualitative study focused on understanding current treatment approaches for multiple myeloma (MM) patients and identifying unmet needs. Additionally, it aimed to evaluate the potential profile of new products for MM. The study targeted a specific group of hematologists administering or well-versed in CAR-T therapy, one of the most advanced treatments for hematological cancers.
The recruitment process spanned three weeks, followed by a five-day interview period with nine participants. Targeting this sample was challenging due to the specialized nature of CAR-T therapy. However, the study successfully demonstrated our capability to reach and engage with this niche group of healthcare professionals, providing valuable insights into the current landscape and prospects for MM treatment.
Insights into Treatment Approaches for CKD and Hypertension in Japan
This qualitative study aimed to understand the current treatment landscape for chronic diseases such as chronic kidney disease (CKD) and hypertension, and to gauge potential prescription behavior for new mechanisms of action (MOAs). The study involved 36 participants, including nephrologists, cardiologists, and internal medicine specialists.
The recruitment process spanned three weeks, followed by a nine-day interview period. We conducted both in-person and online interviews, with three participants interviewed in person and 33 online. This flexibility highlighted our commitment to adapting to participants' preferences and circumstances. Despite the challenges of managing a large sample size and coordinating multiple interview formats, the study provided valuable insights into the current treatment situation for CKD and hypertension, as well as potential prescribing patterns for novel MOAs.
Understanding Unmet Needs of PsO and PsA Patients in China and Japan
The three-phase study aimed to understand the unmet needs and challenges faced by PsO and PsA patients in China and Japan. The study involved a pulse survey, an online bulletin board, and follow-up qualitative interviews.
Patients completed a 10-minute pulse survey before participating in a two-week online bulletin board discussion with the moderator and other patients. Following this, patients joined a 60-minute follow-up qualitative interview. We successfully recruited 30 patients in Japan and 40 patients in China, including those with only PsO or PsA and those with both conditions. Recruitment was completed within four weeks.
Orthopedic device market access study in China
The client was targeting n=23 heads of departments (HODs) from Top 50/100 Orthopedic hospitals in China for 60-minute qualitative TDIs.
The sample included HODs from orthopedic, devices/equipment, finance, and procurement - as well as C-suite professionals.
The objective of the study was to understand the economic value drivers for new orthopedic devices in China.
Advanced NSCLC patient journey study in China and Hong Kong
Client was aiming to conduct an study including qualitative IDIs online quantitative interviews.
The method included 8 paired patient and caregiver interviews, 52 HCP interviews, 6 KOL interviews, and 2 pathology interviews in China.
The sample size in Hong Kong was a bit smaller. We completed 3 paired patient and caregiver interviews, 26 HCP interviews and 2 payor interviews.
The objective of the study was to understand the current market landscape and future opportunities for advanced NSCLC treatment. An in-home observation method was used to understand patient journey in-depth.
Vaccines study across APAC
The client was aiming to conduct a large-scale qualitative study (n=30s per country) concerning market entry assessment across APAC countries (China, Japan, Korea, Taiwan, Australia) for vaccines targeting two infectious disease areas.
The objective of the study was to speak with various stakeholders, such as current and ex-payors, HCPs, patients and KOLs about the need for / value of a vaccine.
Insights into Treatment Approaches for CKD and Hypertension in Japan
This qualitative study aimed to understand the current treatment landscape for chronic diseases such as chronic kidney disease (CKD) and hypertension, and to gauge potential prescription behavior for new mechanisms of action (MOAs). The study involved 36 participants, including nephrologists, cardiologists, and internal medicine specialists.
The recruitment process spanned three weeks, followed by a nine-day interview period. We conducted both in-person and online interviews, with three participants interviewed in person and 33 online. This flexibility highlighted our commitment to adapting to participants' preferences and circumstances. Despite the challenges of managing a large sample size and coordinating multiple interview formats, the study provided valuable insights into the current treatment situation for CKD and hypertension, as well as potential prescribing patterns for novel MOAs.